MoonLake Immunotherapeutics (MLTX) EPS (Basic) (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) posted quarterly EPS (Basic) of -$0.98 for Q1 2026, down 52.48% year-over-year from -$2.06 in Q1 2025, and little changed quarter-over-quarter from -$0.98 in Q4 2025.
MoonLake Immunotherapeutics (MLTX) EPS (Basic) (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' EPS (Basic) history runs 6 years deep, the most recent figure standing at -$0.98 for Q1 2026.
- In Q1 2026, EPS (Basic) fell 52.48% year-over-year to -$0.98; the TTM figure through Mar 2026 stood at -$3.64 (down 55.72% YoY), while the FY2025 annual figure was -$3.57, down 85.27% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.98, roughly flat from -$0.98 in the prior quarter.
- The five-year high for EPS (Basic) was -$0.16 in Q4 2023, with the low at -$3.17 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.56 (2022), against an average of -$0.71.
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) slumped 47644.71% in 2022, then soared 90.12% in 2023.
- MoonLake Immunotherapeutics' EPS (Basic) stood at -$0.56 in 2022, then jumped by 71.37% to -$0.16 in 2023, then sank by 359.6% to -$0.74 in 2024, then tumbled by 32.47% to -$0.98 in 2025, then slipped by 0.05% to -$0.98 in 2026.
- Business Quant data shows MLTX's EPS (Basic) at -$0.98 in Q1 2026, -$0.98 in Q4 2025, and -$1.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | MoonLake Immunotherapeutics | 1.40 Bn | 864.68 Mn | - | -0.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.84 |
| Mar 31, 2026 | -0.98 |
| Dec 31, 2025 | -0.98 |
| Sep 30, 2025 | -1.12 |
| Jun 30, 2025 | -0.89 |
| Mar 31, 2025 | -0.64 |
| Dec 31, 2024 | -0.74 |
| Sep 30, 2024 | -0.57 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.16 |
| Sep 30, 2023 | -0.22 |
| Jun 30, 2023 | -0.28 |
| Mar 31, 2023 | -0.31 |
| Dec 31, 2022 | -0.56 |
| Sep 30, 2022 | -0.40 |
| Jun 30, 2022 | -0.49 |
| Mar 31, 2022 | -3.17 |
| Dec 31, 2021 | -4.50 |
| Sep 30, 2021 | -2.63 |